{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "10420081", "DateCompleted": {"Year": "1999", "Month": "08", "Day": "24"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "18"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "1021-7770", "JournalIssue": {"Volume": "6", "Issue": "4", "PubDate": {"Year": "1999", "Season": "Jul-Aug"}}, "Title": "Journal of biomedical science", "ISOAbbreviation": "J Biomed Sci"}, "ArticleTitle": "Anticancer drug design based on plant-derived natural products.", "Pagination": {"StartPage": "236", "EndPage": "250", "MedlinePgn": "236-50"}, "Abstract": {"AbstractText": ["This review article focuses on recent research in my laboratory on various classes of compounds that possess potent antitumor activity. These compounds were obtained by bioactivity- and mechanism of action-directed isolation and characterization coupled with rational drug design-based modification and analog synthesis. Structural modification, structure-activity relationship, and mechanism of action studies will be discussed."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products Laboratory, Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill, Nc 27599-7360, USA."}], "LastName": "Lee", "ForeName": "K H", "Initials": "KH"}], "GrantList": [{"GrantID": "CA 17625", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "CA 54508", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, P.H.S.", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Biomed Sci", "NlmUniqueID": "9421567", "ISSNLinking": "1021-7770"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Enzyme Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Topoisomerase I Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Topoisomerase II Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Tubulin Modulators"}, {"RegistryNumber": "6PLQ3CP4P3", "NameOfSubstance": "Etoposide"}, {"RegistryNumber": "SML2Y3J35T", "NameOfSubstance": "Colchicine"}, {"RegistryNumber": "XT3Z54Z28A", "NameOfSubstance": "Camptothecin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["analogs & derivatives"], "DescriptorName": "Camptothecin"}, {"QualifierName": ["analogs & derivatives"], "DescriptorName": "Colchicine"}, {"QualifierName": [], "DescriptorName": "Drug Design"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Enzyme Inhibitors"}, {"QualifierName": ["analogs & derivatives", "metabolism"], "DescriptorName": "Etoposide"}, {"QualifierName": ["chemistry"], "DescriptorName": "Flavonoids"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants"}, {"QualifierName": [], "DescriptorName": "Topoisomerase I Inhibitors"}, {"QualifierName": [], "DescriptorName": "Topoisomerase II Inhibitors"}, {"QualifierName": [], "DescriptorName": "Tubulin Modulators"}], "NumberOfReferences": "68"}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1999", "Month": "7", "Day": "27"}, {"Year": "1999", "Month": "7", "Day": "27", "Hour": "0", "Minute": "1"}, {"Year": "1999", "Month": "7", "Day": "27", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10420081", "10.1007/BF02253565", "25392"]}}]}